Linnaeus Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Linnaeus Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma (NCT06624644) | Linnaeus Therapeutics, Inc. | 2025-08-06 |
| Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab (NCT04130516) | Linnaeus Therapeutics, Inc. | 2019-10-21 |
Track Linnaeus Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.